Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox Pretreatment for Chemical Peel in Crow's Feet
NCT01586819Phase 3Completed
- Sponsor
- Loyola University Chicago
- Start
- Sep 2011
- Primary completion
- May 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of botulinum toxin type A in lateral canthal rhytides (2 arms), sponsored by Loyola University Chicago. Primary endpoints: Posttreament Results of Chemical Peel if Botox A is Added as Pre-treatment at 12 weeks and Change From Pre- to Post-treatment Scores of Chemical Peel if Botox A is Added as Pre-treatment at 12 weeks. Started Sep 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
lateral canthal rhytides
Beyond the preview
Go deeper on NCT01586819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01586819.